|
The Effect of Body Mass Index on Short-term Results of HTO
RECRUITINGN/ASponsored by Egymedicalpedia
Actively Recruiting
PhaseN/A
SponsorEgymedicalpedia
Started2024-07-10
Est. completion2025-07-01
Eligibility
Age40 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06590818
Summary
The knee joint plays a major role in weight transmission of the body in day-to-day activities. The biomechanics of the knee and malalignment in lower limb anatomy are major risk factors for chronic knee pain, leaving Total Knee Arthroplasty (TKA) as the best and most successful option for patients with end-stage osteoarthritis (OA)
Eligibility
Age: 40 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria: * Meet the diagnostic criteria for knee osteoarthritis and only have one knee * No serious underlying medical disease * Conservative treatment is ineffective and there is a willingness for surgery * X-ray shows degeneration limited to the medial joint space (Ahlback grade ≥ grade II) * Knee flexion range of motion \> 90°, varus deformity \< 15°, flexion contracture \< 5°. * Clinical examination shows intact anterior cruciate ligament and collateral ligament, tenderness point is limited to the medial joint space, and the lateral compartment and patellofemoral joint are intact. Exclusion Criteria: * knee osteoarthritis caused by infection, blood-related or autoimmune diseases. * severe obesity (BMI\>35 kg/m 2 ) or morbid obesity (obesity caused by diseases such as hypercortisolism and hypothyroidism, BMI≥30 kg/m 2 ).
Conditions3
ArthritisOsteo Arthritis KneeVarus Knee
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorEgymedicalpedia
Started2024-07-10
Est. completion2025-07-01
Eligibility
Age40 Years – 60 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06590818